Delivery Order SPE2DB24D2100-SPE2DB25FBEWQ
Award Date
6/24/25
Potential Completion Date
7/16/25
Potential Value
$29K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of VYEPTI 100 MG/ML VIALML, a medical product, with a ceiling value of $8,100.26 and a period of performance through July 8, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a pharmaceutical distributor and healthcare solutions provider. The $20,829.24 firm-fixed-price contract is for the supply of VYEPTI 100 MG/ML VIALML, a pharmaceutical product. The contract is not designated as a set-aside and has an ultimate completion date of June 10, 2025. AmerisourceBergen Drug Corp also holds a substantial $999,999,999.00 Indefinite...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to supply VYEPTI 100 MG/ML VIAL medication. The contract has a ceiling value of $3,202.53 and a period of performance through August 22, 2024. It is a Firm Fixed Price, Delivery Order contract type with no set-aside designation. Amerisourcebergen is the prime contractor providing these pharmaceutical products to support military treatment...
This is a delivery order for $3,471.54 awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for 100 mg/mL vials of the drug VYEPTI, with a period of performance through March 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) the vendor holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC provides a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VYEPTI 100 MG/ML VIALML. The contract has a firm fixed price, with a ceiling value of $46,287.20 and a period of performance ending on June 12, 2025. AmerisourceBergen Drug Corp is the prime contractor, and the contract is not set aside. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This contract award, valued at $5,785.90, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of VYEPTI 100 MG/ML vials, a prescription medication, with a completion date of January 28, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a $46,287.20 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of VYEPTI 100 mg/ml vials, a specialty pharmaceutical product. The contract is not designated under any set-aside program. It is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The contract is for the supply of VYEPTI 100 MG/ML VIALML, a pharmaceutical product, with a ceiling value of $2,135.02 and an ultimate completion date of September 24, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of the pharmaceutical product VYEPTI 100 mg/mL. The fixed-price contract, valued at $3,202.53, has an ultimate completion date of August 1, 2024. Amerisourcebergen, a major pharmaceutical distributor, leverages its extensive supply chain network to fulfill government contracts, particularly for the Department of Defense (DoD) and the...
This is a delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,628.72 firm fixed price contract is for the supply of VYEPTI 100 MG/ML VIALML, with a performance period ending on July 14, 2025. Amerisourcebergen Drug Corp is not a small business, as the contract is not set aside. The company holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop...